BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 16049009)

  • 1. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase.
    Byfield MP; Murray JT; Backer JM
    J Biol Chem; 2005 Sep; 280(38):33076-82. PubMed ID: 16049009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutrient sensing in the mTOR/S6K1 signalling pathway.
    Gulati P; Thomas G
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):236-8. PubMed ID: 17371247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase.
    Adochio R; Leitner JW; Hedlund R; Draznin B
    Endocrinology; 2009 Mar; 150(3):1165-73. PubMed ID: 18948408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
    Khamzina L; Veilleux A; Bergeron S; Marette A
    Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hvps34, an ancient player, enters a growing game: mTOR Complex1/S6K1 signaling.
    Nobukuni T; Kozma SC; Thomas G
    Curr Opin Cell Biol; 2007 Apr; 19(2):135-41. PubMed ID: 17321123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase.
    Kimball SR; Siegfried BA; Jefferson LS
    J Biol Chem; 2004 Dec; 279(52):54103-9. PubMed ID: 15494402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.
    Liu Y; Fanburg BL
    Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of TRB3 on insulin and nutrient-stimulated hepatic p70 S6 kinase activity.
    Matsushima R; Harada N; Webster NJ; Tsutsumi YM; Nakaya Y
    J Biol Chem; 2006 Oct; 281(40):29719-29. PubMed ID: 16887816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mammalian target of rapamycin-p70 ribosomal S6 kinase but not phosphatidylinositol 3-kinase-Akt signaling is responsible for fibroblast growth factor-9-induced cell proliferation.
    Wing LY; Chen HM; Chuang PC; Wu MH; Tsai SJ
    J Biol Chem; 2005 May; 280(20):19937-47. PubMed ID: 15760907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
    Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
    Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status.
    Cheng SW; Fryer LG; Carling D; Shepherd PR
    J Biol Chem; 2004 Apr; 279(16):15719-22. PubMed ID: 14970221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.
    Smith EM; Finn SG; Tee AR; Browne GJ; Proud CG
    J Biol Chem; 2005 May; 280(19):18717-27. PubMed ID: 15772076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells.
    Tremblay F; Marette A
    J Biol Chem; 2001 Oct; 276(41):38052-60. PubMed ID: 11498541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic receptor-mediated activation of p70 S6 kinase 1 (S6K1) in 1321N1 astrocytoma cells: permissive role of phosphoinositide 3-kinase.
    Tang X; Wang L; Proud CG; Downes CP
    Biochem J; 2003 Aug; 374(Pt 1):137-43. PubMed ID: 12747804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.
    Suh JM; Song JH; Kim DW; Kim H; Chung HK; Hwang JH; Kim JM; Hwang ES; Chung J; Han JH; Cho BY; Ro HK; Shong M
    J Biol Chem; 2003 Jun; 278(24):21960-71. PubMed ID: 12668683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S6K1 plays a key role in glial transformation.
    Nakamura JL; Garcia E; Pieper RO
    Cancer Res; 2008 Aug; 68(16):6516-23. PubMed ID: 18701474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase.
    Holz MK; Blenis J
    J Biol Chem; 2005 Jul; 280(28):26089-93. PubMed ID: 15905173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.
    Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC
    J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.